RAGGIO ITALGENE SPA has a total of 18 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Italy. Its main competitors in its focus markets biotechnology and pharmaceuticals are GUANGZHOU FIRST MUNICIPAL PEOPLE S HOSPITAL, VIRGINIA MASON RES CENTER and SEASUN BIOMATERIALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Italy | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United Kingdom | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Martinazzo Giorgio | 10 |
#2 | Marcolini Stanislavo | 9 |
#3 | Bichi Roberta | 8 |
#4 | Turchetti Elisabetta | 8 |
#5 | Luini Alberto | 3 |
#6 | Facchiano Antonio | 3 |
#7 | Pelliccia Angela | 3 |
#8 | Facchiano Francesco | 3 |
#9 | Croce Carlo Maria | 2 |
#10 | Russo Giandomenico | 2 |
Publication | Filing date | Title |
---|---|---|
AU1279895A | Peptide effective as substrate and/or inhibitor of the transglutaminase enzyme and use thereof for diagnostics and therapeutics | |
AU7992494A | Assay for the detection of genetic abnormalities | |
GB9414933D0 | Enrichment and detection of nucleic acids | |
GB9414934D0 | Method and reagents for the detection of target nuceic acid sequences | |
AU6678894A | Diagnostic probes and their use in detecting human chromosomal abnormalities | |
ITRM920605D0 | Antisense oligonucleotides and their use | |
AU666648B2 | Assay and kit for the detection of chromosomal abnormalities |